{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:53:21Z","timestamp":1793832801399,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Research Funds on Biomedical Translation of China-Japan Friendship Hospital"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072839"],"award-info":[{"award-number":["82072839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303795"],"award-info":[{"award-number":["82303795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52422316"],"award-info":[{"award-number":["52422316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373124"],"award-info":[{"award-number":["52373124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52221006"],"award-info":[{"award-number":["52221006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52033001"],"award-info":[{"award-number":["52033001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["RDJP2022-69"],"award-info":[{"award-number":["RDJP2022-69"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["BMU2023YFJHPY009"],"award-info":[{"award-number":["BMU2023YFJHPY009"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["BUCTRC201912"],"award-info":[{"award-number":["BUCTRC201912"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["PT2403"],"award-info":[{"award-number":["PT2403"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2127000305"],"award-info":[{"award-number":["2127000305"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peking University People\u2019s Hospital"},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["2023-NHLHCRF-YXHZ-TJMS-01"],"award-info":[{"award-number":["2023-NHLHCRF-YXHZ-TJMS-01"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["2024-NHLHCRF-YXHZ-MS-01"],"award-info":[{"award-number":["2024-NHLHCRF-YXHZ-MS-01"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113905","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:11:40Z","timestamp":1748545900000},"page":"113905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Self-enhanced ROS-responsive camptothecin prodrug nanoparticles elicit safe and efficient intravesical instillation therapy of bladder cancer"],"prefix":"10.1016","volume":"384","author":[{"given":"Kunpeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2025.113905_bb0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113905_bb0010","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.113905_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2025.113905_bb0020","article-title":"The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113905_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175024","article-title":"Intravesical combination therapies for non-muscle invasive bladder cancer: recent advances and future directions","volume":"926","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113905_bb0035","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.urolonc.2017.06.043","article-title":"Current clinical trials in non-muscle invasive bladder cancer","volume":"35","author":"Siddiqui","year":"2017","journal-title":"Urol. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113905_bb0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/imt.10.1","article-title":"Update on intravesical agents for non-muscle-invasive bladder cancer","volume":"2","author":"Shariat","year":"2010","journal-title":"Immunotherapy"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113905_bb0045","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.euo.2024.06.005","article-title":"The role of mitomycin C in intermediate-risk non\u2013muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"7","author":"Scilipoti","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"24","key":"10.1016\/j.jconrel.2025.113905_bb0050","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.3390\/cancers16244125","article-title":"Comparisons of Intravesical treatments with mitomycin C, gemcitabine, and docetaxel for recurrence and progression of non-muscle invasive bladder cancer: updated systematic review and meta-analysis","volume":"16","author":"Matloubieh","year":"2024","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.jconrel.2025.113905_bb0055","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/ph16101456","article-title":"Prospects of topoisomerase inhibitors as promising anti-cancer agents","volume":"16","author":"Yakkala","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113905_bb0060","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/genes14071346","article-title":"Therapeutic targeting of DNA replication stress in cancer","volume":"14","author":"Gu","year":"2023","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urolonc.2020.09.031","article-title":"Bacillus Calmette-Guerin (BCG): its fight against pathogens and cancer","volume":"39","author":"Sfakianos","year":"2021","journal-title":"Urol. Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113905_bb0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0075","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/curroncol31020079","article-title":"BCG and alternative therapies to BCG therapy for non-muscle-invasive bladder cancer","volume":"31","author":"Lidagoster","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jconrel.2025.113905_bb0080","article-title":"Current researches on nanodrug delivery systems in bladder cancer intravesical chemotherapy","volume":"12","author":"Lu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2025.113905_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.778973","article-title":"Functional nanomedicines for targeted therapy of bladder cancer","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.37349\/eds.2023.00008","article-title":"Nano theranostics involved in bladder cancer treatment","volume":"1","author":"Liu","year":"2023","journal-title":"Explor. Drug Sci."},{"key":"10.1016\/j.jconrel.2025.113905_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114062","article-title":"Current advances in the application of nanomedicine in bladder cancer","volume":"157","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113905_bb0100","doi-asserted-by":"crossref","first-page":"2110490","DOI":"10.1002\/adma.202110490","article-title":"Co-delivery of precisely prescribed multi-prodrug combination by an engineered nanocarrier enables efficient individualized cancer chemotherapy","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0105","first-page":"433","article-title":"Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer","volume":"6","author":"Liang","year":"2021","journal-title":"Bioact. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0110","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1021\/acsnano.9b06689","article-title":"Fluorinated chitosan to enhance transmucosal delivery of sonosensitizer-conjugated catalase for sonodynamic bladder cancer treatment post-intravesical instillation","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"issue":"28","key":"10.1016\/j.jconrel.2025.113905_bb0115","doi-asserted-by":"crossref","first-page":"2308456","DOI":"10.1002\/smll.202308456","article-title":"Photodynamic therapy derived personalized whole cell tumor vaccine prevents postsurgery tumor recurrence and metastasis","volume":"20","author":"Yang","year":"2024","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113905_bb0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/acs.biomac.7b01676","article-title":"CD44-targeted facile enzymatic activatable chitosan nanoparticles for efficient antitumor therapy and reversal of multidrug resistance","volume":"19","author":"Zhang","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2025.113905_bb0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2023.01.001","article-title":"Mechanisms and strategies to enhance penetration during intravesical drug therapy for bladder cancer","volume":"354","author":"Zhang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113905_bb0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jconrel.2020.03.028","article-title":"Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer","volume":"324","author":"Xu","year":"2020","journal-title":"J. Control. Release"},{"issue":"31","key":"10.1016\/j.jconrel.2025.113905_bb0135","doi-asserted-by":"crossref","first-page":"2202834","DOI":"10.1002\/smll.202202834","article-title":"Deep-penetrating triple-responsive prodrug nanosensitizer actuates efficient chemoradiotherapy in pancreatic ductal adenocarcinoma models","volume":"18","author":"Tang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.113905_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121305","article-title":"Cascade-responsive nano-assembly for efficient photothermal-chemo synergistic inhibition of tumor metastasis by targeting cancer stem cells","volume":"280","author":"Zhu","year":"2022","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113905_bb0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-activatable polymer\u2013drug conjugate augments tumour penetration and treatment efficacy","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"21","key":"10.1016\/j.jconrel.2025.113905_bb0150","doi-asserted-by":"crossref","first-page":"2309655","DOI":"10.1002\/adma.202309655","article-title":"STING membrane prevents post-surgery tissue adhesion and tumor recurrence of colorectal cancer","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113905_bb0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.15212\/bioi-2021-0011","article-title":"The integration of reactive oxygen species generation and prodrug activation for cancer therapy","volume":"3","author":"Shi","year":"2022","journal-title":"Bio Integr."},{"issue":"34","key":"10.1016\/j.jconrel.2025.113905_bb0160","doi-asserted-by":"crossref","first-page":"2204629","DOI":"10.1002\/adfm.202204629","article-title":"A multimodal therapeutic nanoplatform overcoming tumor hypoxia heterogeneity for improved tumor chemoradiotherapy","volume":"32","author":"Zhang","year":"2022","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113905_bb0165","first-page":"5381692","article-title":"Understanding of ROS-inducing strategy in anticancer therapy","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2025.113905_bb0170","article-title":"Reactive oxygen species-responsive polymer drug delivery systems","volume":"11","author":"Liu","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113905_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009409","article-title":"Reactive oxygen species: Janus-faced molecules in the era of modern cancer therapy","volume":"12","author":"O\u2019Reilly","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113905_bb0180","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41419-024-06939-5","article-title":"Oxidative cell death in cancer: mechanisms and therapeutic opportunities","volume":"15","author":"An","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113905_bb0185","doi-asserted-by":"crossref","first-page":"2006892","DOI":"10.1002\/adma.202006892","article-title":"Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy","volume":"33","author":"Fu","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113905_bb0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.actbio.2022.04.022","article-title":"Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy","volume":"145","author":"Meng","year":"2022","journal-title":"Acta Biomater."},{"issue":"29","key":"10.1016\/j.jconrel.2025.113905_bb0195","doi-asserted-by":"crossref","first-page":"25654","DOI":"10.1021\/acsami.9b01433","article-title":"Tailored design of an ROS-responsive drug release platform for enhanced tumor therapy via \u201csequential induced activation processes\u201d","volume":"11","author":"Luan","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113905_bb0200","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jconrel.2022.05.031","article-title":"Bladder cancer selective chemotherapy with potent NQO1 substrate co-loaded prodrug nanoparticles","volume":"347","author":"Jiao","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113905_bb0205","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1002\/mco2.187","article-title":"Multifunctional nanoparticle for cancer therapy","volume":"4","author":"Gao","year":"2020","journal-title":"MedComm"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113905_bb0210","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.113905_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2017.11.023","article-title":"Acid-activatable oxidative stress-inducing polysaccharide nanoparticles for anticancer therapy","volume":"269","author":"Yoo","year":"2018","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0220","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/acs.biomac.8b01802","article-title":"Engineered polymeric micelles for combinational oxidation anticancer therapy through concurrent HO-1 inhibition and ROS generation","volume":"20","author":"Noh","year":"2019","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3835(03)00238-6","article-title":"Cinnamaldehyde induces apoptosis by ROS-mediated mitochondrial permeability transition in human promyelocytic leukemia HL-60 cells","volume":"196","author":"Ka","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2025.113905_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121954","article-title":"A novel ROS-activable self-immolative prodrug for tumor-specific amplification of oxidative stress and enhancing chemotherapy of mitoxantrone","volume":"293","author":"Zhang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113905_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.124628","article-title":"Tumor-targeted supramolecular catalytic nanoreactor for synergistic chemo\/chemodynamic therapy via oxidative stress amplification and cascaded Fenton reaction","volume":"390","author":"Xu","year":"2020","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2025.113905_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121128","article-title":"Reactive oxygen species-activatable self-amplifying Watson-crick base pairing-inspired supramolecular nanoprodrug for tumor-specific therapy","volume":"277","author":"Xu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113905_bb0245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.actbio.2022.06.035","article-title":"A self-amplifying ROS-sensitive prodrug-based nanodecoy for circumventing immune resistance in chemotherapy-sensitized immunotherapy","volume":"149","author":"Zhang","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.113905_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.131453","article-title":"ROS-responsive amphiphilic block copolymer-drug conjugate: design, synthesis and potential as an efficient drug delivery system via a positive feedback strategy","volume":"425","author":"Wang","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113905_bb0255","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase I inhibitors: camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113905_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb07020.x","article-title":"Mechanism of action of camptothecin","volume":"922","author":"Liu","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.113905_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115710","article-title":"The recent developments of camptothecin and its derivatives as potential anti-tumor agents","volume":"260","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113905_bb0270","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543770902773437","article-title":"Novel camptothecin derivatives as topoisomerase I inhibitors","volume":"19","author":"Basili","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113905_bb0275","doi-asserted-by":"crossref","first-page":"16875","DOI":"10.1021\/acsnano.0c05722","article-title":"Reactive oxygen species activatable heterodimeric prodrug as tumor-selective nanotheranostics","volume":"14","author":"Jiang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113905_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.649048","article-title":"Reactive oxygen species responsive polymers for drug delivery systems","volume":"9","author":"Gao","year":"2021","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113905_bb0285","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/btm2.10014","article-title":"ROS-responsive drug delivery systems","volume":"1","author":"Liang","year":"2016","journal-title":"Bioeng. Transl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113905_bb0290","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nantod.2016.04.008","article-title":"Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines","volume":"11","author":"Wang","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.113905_bb0295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2016.12.041","article-title":"Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma","volume":"259","author":"Guo","year":"2017","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113905_bb0300","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/cbin.10459","article-title":"Effect of the surface modification, size, and shape on cellular uptake of nanoparticles","volume":"39","author":"Salatin","year":"2015","journal-title":"Cell Biol. Int."},{"issue":"10","key":"10.1016\/j.jconrel.2025.113905_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101686","article-title":"Chitosan nanoparticles at the biological interface: implications for drug delivery","volume":"13","author":"Aibani","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113905_bb0310","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/21691401.2019.1577876","article-title":"Chitosan nanoparticles induced the antitumor effect in hepatocellular carcinoma cells by regulating ROS-mediated mitochondrial damage and endoplasmic reticulum stress","volume":"47","author":"Jiang","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.113905_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120671","article-title":"Reduction-responsive dehydroepiandrosterone prodrug nanoparticles loaded with camptothecin for cancer therapy by enhancing oxidation therapy and cell replication inhibition","volume":"603","author":"Xu","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113905_bb0320","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/cancers14010190","article-title":"3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs","volume":"14","author":"Barbosa","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.jconrel.2025.113905_bb0325","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.7150\/thno.15156","article-title":"Phenylboronic acid-mediated tumor targeting of chitosan nanoparticles","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:58:07Z","timestamp":1779512287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":65,"alternative-id":["S0168365925005255"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113905","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-enhanced ROS-responsive camptothecin prodrug nanoparticles elicit safe and efficient intravesical instillation therapy of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113905"}}